Acute Coronary Syndrome
Contemporary Trends in the Use of Ticagrelor in ACS Patients National Cardiovascular Data Registry
According to a recent registry study published in JAHA, there is an increase in the use of ticagrelor in hospital and at discharge, with simultaneous decrease in the use of clopidogrel and prasugrel, in patients with acute myocardial infarction (AMI).
CTA Verified High Risk Coronary Plaque Predicts ACS ICONIC TRIAL
Coronary computed tomography angiography (CTA)-guided vulnerable plaque characteristics have predictive value for future acute coronary syndrome (ACS) in high-risk patients according to Incident COronary EveNts Identified by Computed Tomography (ICONIC) trial which is published in the Journal of the American College of Cardiology.
Cardiac MRI Improves Long-Term Risk Stratification After STEMI
Cardiac magnetic resonance (CMR) imaging provides useful prognostic information in revascularized ST-segment elevation (STEMI) patients, according to a recent study published in June 2018, in the Journal of the American College of Cardiology.
ORBITA Trial & Panel Discussion
Dr. Kirk Garratt, Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss
Podcast: Download
ORBITA Trial & Panel Discussion Dr. Kirk Garratt, Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss
Prior Silent MI Is Associated with Worse Outcomes in Patients with AMI
A recent observational longitudinal study published in the Journal of American College of Cardiology showed that previous silent myocardial infarction (MI) was found in 8.2% of patients presenting with first acute myocardial infarction (AMI). Previous silent MI was detected by late gadolinium enhancement- cardiac magnetic resonance (LGE-CMR). Continue reading
Pre-PCI Impella Device Improves Outcome in Acute MI complicated by Cardiogenic Shock (AMICS)
A non-randomized study published in the American Heart Journal showed increased survival rates in patients with Impella device being used as the first support strategy for patients with acute myocardial infarction complicated by cardiogenic shock (AMICS) when invasive hemodynamic monitoring was used, and at centers with higher Impella implantation volume. Continue reading
The Use of Supplemental Oxygen in Suspected Acute MI is of no Benefit
The use of supplemental oxygen in normoxemic patients with suspected acute myocardial infarction is of no clinical benefit, says a new article in the British Medical Journal. Continue reading
EAGLES- A Randomized Clinical Trial Showing No Evidence of Smoking Cessation Treatments Association with MACE
EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study), a randomized clinical trial, published in the Journal of the American Medical Association, provides evidence that smoking cessation medications do not increase the risk of serious cardiovascular events in the general population of smokers. Continue reading
High Sensitivity Troponin I and Stable Coronary Artery Disease
A recent study published in the Journal of American College of Cardiology found an association between elevated concentrations of high sensitivity troponin I (hsTnI) with increasing prevalence of coronary artery disease (CAD) in stable patients, who were suspected of coronary artery disease and underwent non-emergent coronary computed tomography angiography (CTA).
Does Operator PCI Volume Influence Mortality?
The number of procedures performed by the operator of a Percutaneous Coronary Intervention (PCI) in the previous year has no impact on the 30-day mortality, according to a recent UK study published in the European Heart Journal. Continue reading
Do Procedure and Coronary Lesion Characteristics Impact Clinical Outcomes in Atrial Fibrillation Patients Undergoing PCI?
According to a post-hoc analysis of the PIONEER AF-PCI trial that was recently published in the Journal of American College of Cardiology, there was no impact of complex coronary lesions, stent characteristics, or vascular approach on efficacy or safety outcomes among stented atrial fibrillation (AF) patients who received either rivaroxaban or Vitamin K Antagonists (VKA)-based dual or triple therapy. Continue reading
Should Patients with Acute Chest Pain Undergo Noninvasive Testing After the Clinical Diagnosis is Made?
The use of noninvasive cardiac tests such as coronary computed tomographic angiography (CCTA) or stress testing for patients presenting to the emergency department with chest pain is not associated with a better clinical outcome when compared to the conventional method for diagnosing acute coronary syndrome, according to a recent study published in the Journal of American Medical Association. Continue reading
